文献速递神经免疫神经重症与神经感染

需呼吸支持的CNS脱髓鞘发作:MOG与AQP4抗体比较

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
PubMed 文献 · Neurology · 2021-08-13

该回顾性研究纳入Mayo Clinic 1996至2020年MOGAD和AQP4-NMOSD患者,比较需呼吸支持的发作频率、特征和结局。MOGAD和AQP4-NMOSD中需呼吸支持的发作均罕见(分别为2.9%和2.2%),但AQP4-NMOSD通气时间更长、死亡率更高,且Black种族在需通气发作中占比更高。

要点

  • MOGAD和AQP4-NMOSD需呼吸支持的发作均罕见,比例分别为2.9%和2.2%。
  • MOGAD通气原因多为癫痫/脑炎/脑脊髓炎,AQP4-NMOSD多为颈髓炎致气道保护不能。
  • AQP4-NMOSD通气时间更长且病死率更高,Black种族发作风险更高。

核心结论

  • MOGAD和AQP4-NMOSD需呼吸支持的发作均罕见,但适应证和结局不同。
  • AQP4-NMOSD需通气发作的致残和致死风险可能高于MOGAD。
  • Black种族在AQP4-NMOSD需通气发作中占比更高,可能与健康不平等相关。

研究设计与样本

  • 通过电子病历检索需无创或有创通气的发作,纳入标准包括发作相关呼吸支持、抗体阳性并符合诊断标准及临床资料充分。
  • 收集人口学、合并症、呼吸支持指征和时长、MRI、治疗和结局数据,并比较需呼吸支持与无需者的种族分布。

主要发现

  • 需呼吸支持的发作在MOGAD中占8/279(2.9%),在AQP4-NMOSD中占11/503(2.2%),组间p=0.63。
  • 发作年龄中位数MOGAD为31.5岁(范围5-47),AQP4-NMOSD为43岁(范围14-65),p=0.01。
  • 女性比例MOGAD为3/8(38%),AQP4-NMOSD为10/11(91%),p=0.04。
  • MOGAD通气原因包括癫痫发作/脑炎/脑脊髓炎(5例,62.5%)和单侧皮质脑炎(3例,37.5%);AQP4-NMOSD包括颈髓炎(9例,82%)、菱脑炎(1例,9%)及两者兼有(1例,9%)。
  • 通气时长中位数MOGAD为2天(范围1-7天),AQP4-NMOSD为19天(范围6-330天),p=0.01;MOGAD全部恢复,AQP4-NMOSD有2/11(18%)死于发作;AQP4-NMOSD需通气者Black种族占5/11(45%),无需者占88/457(19%),p=0.045。

临床怎么用

  • 临床遇MOGAD或AQP4-NMOSD患者应警惕呼吸支持需求,尽管总体罕见。
  • MOGAD需通气者应关注癫痫、脑炎或脑脊髓炎等病因,AQP4-NMOSD应警惕颈髓炎和菱脑炎。
  • AQP4-NMOSD需通气者可能病程更长、预后更差,需加强监护和个体化治疗。

局限性

  • 回顾性研究设计,可能存在选择和信息偏倚。
  • 样本来自单中心,需通气发作例数少,结果外推需谨慎。
  • 种族差异的具体机制未明确,可能受社会健康不平等影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Severe attacks of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disorder (MOGAD) and aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) may require ventilatory support, but data on episodes are limited, particularly for MOGAD. We sought to compare the frequency, characteristics, and outcomes of MOGAD and AQP4-NMOSD attacks requiring ventilatory support. METHODS: This retrospective descriptive study identified Mayo Clinic patients (January 1, 1996-December 1, 2020) with MOGAD or AQP4-NMOSD and an attack requiring noninvasive or invasive ventilation at Mayo Clinic or an outside facility by searching for relevant terms in their electronic medical record. Inclusion criteria were (1) attack-related requirement for noninvasive (bilevel positive airway pressure or continuous positive airway pressure) or invasive respiratory support (mechanical ventilation); (2) MOG or AQP4 antibody positivity with fulfillment of MOGAD and AQP4-NMOSD clinical diagnostic criteria, respectively; and (3) sufficient clinical details. We collected data on demographics, comorbid conditions, indication for and duration of respiratory support, MRI findings, treatments, and outcomes. The races of those with attacks requiring respiratory support were compared to those without such attacks in MOGAD and AQP4-NMOSD. RESULTS: Attacks requiring ventilatory support were similarly rare in patients with MOGAD (8 of 279, 2.9%) and AQP4-NMOSD (11 of 503 [2.2%]) (p = 0.63). The age at attack (median years [range]) (MOGAD 31.5 [5-47] vs AQP4-NMOSD 43 [14-65]; p = 0.01) and percentage of female sex (MOGAD 3 of 8 [38%] vs AQP4-NMOSD 10 of 11 [91%]; p = 0.04) differed. The reasons for ventilation differed between MOGAD (inability to protect airway from seizure, encephalitis or encephalomyelitis with attacks of acute disseminated encephalomyelitis 5 [62.5%] or unilateral cortical encephalitis 3 [37.5%]) and AQP4-NMOSD (inability to protect airway from cervical myelitis 9 [82%], rhombencephalitis 1 [9%], or combinations of both 1 [9%]). Median ventilation duration for MOGAD was 2 days (range 1-7 days) vs 19 days (range 6-330 days) for AQP4-NMOSD (p = 0.01). All patients with MOGAD recovered, but 2 of 11 (18%) patients with AQP4-NMOSD died of the attack. For AQP4-NMOSD, Black race was overrepresented for attacks requiring ventilatory support vs those without these episodes (5 of 11 [45%] vs 88 of 457 [19%]; p = 0.045). DISCUSSION: Ventilatory support is rarely required for MOGAD and AQP4-NMOSD attacks, and the indications differ. Compared to MOGAD, these attacks in AQP4-NMOSD may have higher morbidity and mortality, and those of Black race were more predisposed, which we suspect may relate to socially mediated health inequality.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Zhao-Fleming HH, Valencia Sanchez C, Sechi E, et al. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. 2021. PMID: 34389648. doi:10.1212/WNL.0000000000012599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。